– ARV-102 was well tolerated in clinical trials for both healthy volunteers and patients with Parkinson’s disease –
– ARV-102 demonstrated dose-dependent cerebrospinal fluid (CSF) exposure in subjects…Read More
You might also be interested in reading CME is letting traders bet on bitcoin volatility, not price, and two firms have already placed bets.